Livelsberger Financial Advisory Holdings Report (13F Filings)

CIK: 0002015721

High-turnover trader

Total reported value

—

Reporting period: 2025-12-31 · Number of holdings: 1

Livelsberger Financial Advisory disclosed 1 holdings in its latest 13F filing for the period ending 2025-12-31, with total reported value of — and a quarterly turnover rate of 100.0%.

Browse other institutions starting with "L"

Personality snowflake

Concentration: 0
Portfolio Stability: 100
Momentum/Contrarian: 50
Sector conviction: 0
Diversification: 2
Sizing Uniformity: —

Sector classification currently covers about 0% of this portfolio's disclosed value; the remainder includes holdings (e.g. unmapped tickers, options, or other security types) not yet covered by our sector mapping.

Recent moves

Sold out ABBV
Sold out AAPL
Sold out ABT
Sold out PH
Sold out MSFT
Sold out XOM

Holdings Map

Top 10 holdings by weight

Full holdings list this quarter

#	Ticker	Issuer	Asset Subclass	Weight	Weight Change	Shares Change	4Q Trend
1	✓	Ikena Oncology INC	Stock-Other	—	—	—

Portfolio Performance

Performance for Q3 2026

—

Performance Last 4 Quarters

+19.9%

Stdev: +11.7%
Beta: +0.33
Alpha: +11.5%
Max Drawdown: -8.8%
Annualized Perf: +17.9%
Batting Avg vs S&P: +52.4%
Sortino: +3.01
Stutzer: +0.43
Treynor: +0.51
Sterling: +1.08
Calmar: +2.04
Information Ratio: +0.02
Tracking Error: +13%
Stdev Down: +5.7%
Winning Months %: +61.9%
Losing Months %: +38.1%
Best 12 Months: +17.3%
Worst 12 Months: +4.8%
Efficiency Ratio: +0.52
Sharpe: +1.48
Stdev Sectors: —
Skewness: -0.15
Kurtosis: -0.49
Upside Potential: +4.7

Reported value over time

Sector allocation

Not enough sector-mapped data yet

Sector allocation over time

Quarterly history

Period	Holdings	Total value	Stability	Top holdings
2025-12-31	1	—	100
2025-09-30	6	$2.7M	16	1ABBV 2AAPL 3ABT Top holdings2025-09-30 1.ABBV 2.AAPL 3.ABT 4.PH 5.MSFT 6.XOM
2025-06-30	85	$5.2M	0	1ABBV 2ABT 3AAPL Top holdings2025-06-30 1.ABBV 2.ABT 3.AAPL 4.XOM 5.MSFT 6.PH 7.RPM 8.NSC 9.ECL 10.FDX
2025-03-31	5	$2.1M	0	1ABBV 2AAPL 3ABT Top holdings2025-03-31 1.ABBV 2.AAPL 3.ABT 4.XOM 5.PH
2024-12-31	6	$2.1M	0	1ABBV 2AAPL 3ABT Top holdings2024-12-31 1.ABBV 2.AAPL 3.ABT 4.XOM 5.PH 6.MSFT
2024-09-30	80	$4.8M	0	1ABBV 2AAPL 3ABT Top holdings2024-09-30 1.ABBV 2.AAPL 3.ABT 4.XOM 5.PH 6.MSFT 7.FDX 8.ELV 9.NSC 10.ECL
2024-06-30	13	$6.7M	0	1MHD 2ABBV 3PHK Top holdings2024-06-30 1.MHD 2.ABBV 3.PHK 4.KTF 5.GRC 6.WELL 7.AAPL 8.XLI 9.ABT 10.XOM
2024-03-31	15	$8.4M	0	1IIM 2MHD 3ABBV Top holdings2024-03-31 1.IIM 2.MHD 3.ABBV 4.PHK 5.GRC 6.KTF 7.WELL 8.AAPL 9.ABT 10.TBLD
2023-12-31	462	$111.8M	0	1PRHSX 2HCAIX 3OAKMX Top holdings2023-12-31 1.PRHSX 2.HCAIX 3.OAKMX 4.FKINX 5.EVIBX 6.PRWCX 7.78355E 8.CSRSX 9.SWVXX 10.EANAX

Holding changes this quarter

Livelsberger Financial Advisory's most significant position changes for 2025-12-31: Sold out: Abbvie INC (ABBV); Sold out: Apple INC (AAPL); Sold out: Abbott Laboratories (ABT); Sold out: Parker Hannifin CORP (PH); Sold out: Microsoft CORP (MSFT).

Position changes disclosed by Livelsberger Financial Advisory for the quarter ending 2025-12-31, including ticker, issuer, weight change, shares change, and action
#	Ticker	Issuer	Weight Change	Shares Change	Action
1	ABBV	Abbvie INC	—	EXIT	Sold out
2	AAPL	Apple INC	—	EXIT	Sold out
3	ABT	Abbott Laboratories	—	EXIT	Sold out
4	PH	Parker Hannifin CORP	—	EXIT	Sold out
5	MSFT	Microsoft CORP	—	EXIT	Sold out
6	XOM	Exxon Mobil CORP	—	EXIT	Sold out
7	✓	Ikena Oncology INC	—	—	Unchanged

Filing History

Period	Filed	Type	EDGAR
2025-12-31	2026-01-07	13F-HR	View on EDGAR
2025-09-30	2025-10-14	13F-HR	View on EDGAR
2025-06-30	2025-07-08	13F-HR	View on EDGAR
2025-03-31	2025-04-08	13F-HR	View on EDGAR
2024-12-31	2025-01-14	13F-HR	View on EDGAR
2024-09-30	2024-10-21	13F-HR	View on EDGAR
2024-06-30	2024-08-05	13F-HR	View on EDGAR
2024-03-31	2024-05-22	13F-HR	View on EDGAR
2023-12-31	2024-03-22	13F-HR	View on EDGAR

FAQ

What is Livelsberger Financial Advisory and what type of investor is it?

Livelsberger Financial Advisory is a investment manager that files SEC Form 13F quarterly, disclosing its U.S. public equity holdings to regulators. As of the most recent reporting period (2025-12-31), the firm manages a tracked equity portfolio valued at approximately —, spread across 1 disclosed positions.

What are Livelsberger Financial Advisory's largest equity positions?

Based on the latest 13F filing, Livelsberger Financial Advisory's top holdings by market value are: 1. Ikena Oncology INC — $0.0

What changes did Livelsberger Financial Advisory make in its most recent portfolio filing?

In the latest quarter, Livelsberger Financial Advisory took a more defensive posture — trimming 0 positions and completely exiting 6 holdings. The largest of these moves: Sold out: Abbvie INC (ABBV); Sold out: Apple INC (AAPL); Sold out: Abbott Laboratories (ABT); Sold out: Parker Hannifin CORP (PH); Sold out: Microsoft CORP (MSFT)

What sectors does Livelsberger Financial Advisory focus on?

Sector breakdown data is not yet available for Livelsberger Financial Advisory. Check back after the next 13F processing cycle.

Peer Institutions

Institutions with a similar AUM

Cowen And Company, LLC

CIK 0000048966

Total reported value

—

1 stks

2024-12-31

Stale — no recent filing

Concentration0.0

Portfolio Stability0.0

Sector conviction0.0

View detail

Kresge Foundation

CIK 0000056822

Total reported value

—

1 stks

2019-12-31

Stale — no recent filing

Concentration0.0

Portfolio Stability0.0

Sector conviction0.0

View detail

Resource America, INC.

CIK 0000083402

Total reported value

—

1 stks

2021-09-30

Stale — no recent filing

Concentration0.0

Portfolio Stability0.0

Sector conviction0.0

View detail

Personality snowflake

Concentration

Portfolio Stability

100

Momentum/Contrarian

Sector conviction

Diversification

Sizing Uniformity

—

Ticker

Issuer

Asset Subclass

Weight

Weight Change

Shares Change

4Q Trend

✓

Ikena Oncology INC

Stock-Other

—

Portfolio Performance

Performance for Q3 2026

—

Performance Last 4 Quarters

+19.9%

Stdev: +11.7%
Beta: +0.33
Alpha: +11.5%
Max Drawdown: -8.8%
Annualized Perf: +17.9%
Batting Avg vs S&P: +52.4%
Sortino: +3.01
Stutzer: +0.43
Treynor: +0.51
Sterling: +1.08
Calmar: +2.04
Information Ratio: +0.02
Tracking Error: +13%
Stdev Down: +5.7%
Winning Months %: +61.9%
Losing Months %: +38.1%
Best 12 Months: +17.3%
Worst 12 Months: +4.8%
Efficiency Ratio: +0.52
Sharpe: +1.48
Stdev Sectors: —
Skewness: -0.15
Kurtosis: -0.49
Upside Potential: +4.7

Quarterly history

Period	Holdings	Total value	Stability	Top holdings
2025-12-31	1	—	100
2025-09-30	6	$2.7M	16	1ABBV 2AAPL 3ABT Top holdings2025-09-30 1.ABBV 2.AAPL 3.ABT 4.PH 5.MSFT 6.XOM
2025-06-30	85	$5.2M	0	1ABBV 2ABT 3AAPL Top holdings2025-06-30 1.ABBV 2.ABT 3.AAPL 4.XOM 5.MSFT 6.PH 7.RPM 8.NSC 9.ECL 10.FDX
2025-03-31	5	$2.1M	0	1ABBV 2AAPL 3ABT Top holdings2025-03-31 1.ABBV 2.AAPL 3.ABT 4.XOM 5.PH
2024-12-31	6	$2.1M	0	1ABBV 2AAPL 3ABT Top holdings2024-12-31 1.ABBV 2.AAPL 3.ABT 4.XOM 5.PH 6.MSFT
2024-09-30	80	$4.8M	0	1ABBV 2AAPL 3ABT Top holdings2024-09-30 1.ABBV 2.AAPL 3.ABT 4.XOM 5.PH 6.MSFT 7.FDX 8.ELV 9.NSC 10.ECL
2024-06-30	13	$6.7M	0	1MHD 2ABBV 3PHK Top holdings2024-06-30 1.MHD 2.ABBV 3.PHK 4.KTF 5.GRC 6.WELL 7.AAPL 8.XLI 9.ABT 10.XOM
2024-03-31	15	$8.4M	0	1IIM 2MHD 3ABBV Top holdings2024-03-31 1.IIM 2.MHD 3.ABBV 4.PHK 5.GRC 6.KTF 7.WELL 8.AAPL 9.ABT 10.TBLD
2023-12-31	462	$111.8M	0	1PRHSX 2HCAIX 3OAKMX Top holdings2023-12-31 1.PRHSX 2.HCAIX 3.OAKMX 4.FKINX 5.EVIBX 6.PRWCX 7.78355E 8.CSRSX 9.SWVXX 10.EANAX

Ticker

Issuer

Weight Change

Shares Change

Action

ABBV

Abbvie INC

—

EXIT

Sold out

AAPL

Apple INC

—

EXIT

Sold out

ABT

Abbott Laboratories

—

EXIT

Sold out

Parker Hannifin CORP

—

EXIT

Sold out

MSFT

Microsoft CORP

—

EXIT

Sold out

XOM

Exxon Mobil CORP

—

EXIT

Sold out

✓

Ikena Oncology INC

—

Unchanged

Filing History

Period	Filed	Type	EDGAR
2025-12-31	2026-01-07	13F-HR	View on EDGAR
2025-09-30	2025-10-14	13F-HR	View on EDGAR
2025-06-30	2025-07-08	13F-HR	View on EDGAR
2025-03-31	2025-04-08	13F-HR	View on EDGAR
2024-12-31	2025-01-14	13F-HR	View on EDGAR
2024-09-30	2024-10-21	13F-HR	View on EDGAR
2024-06-30	2024-08-05	13F-HR	View on EDGAR
2024-03-31	2024-05-22	13F-HR	View on EDGAR
2023-12-31	2024-03-22	13F-HR	View on EDGAR

FAQ

What is Livelsberger Financial Advisory and what type of investor is it?

What are Livelsberger Financial Advisory's largest equity positions?

Based on the latest 13F filing, Livelsberger Financial Advisory's top holdings by market value are: 1. Ikena Oncology INC — $0.0

What changes did Livelsberger Financial Advisory make in its most recent portfolio filing?

What sectors does Livelsberger Financial Advisory focus on?

Sector breakdown data is not yet available for Livelsberger Financial Advisory. Check back after the next 13F processing cycle.